The administration of enrofloxacin (5mg/kg subcutaneously every 12 h for 10 days) failed to eliminate Pasteurella multocida from all naturally and experimentally infected rabbits. Although the enrofloxacin concentrations in serum and in turbinate bones were greater than the determined minimal inhibitory concentrations, P. multocida could be detected in nasal cavities, turbinates, trachea, middle ear and outer ear of experimentally infected rabbits after treatment. It is to be supposed that P. multocida colonizes organs or tissues in which an effective enrofloxacin concentration cannot be achieved. Such sites could be the paranasal sinuses, the auditory tube and the middle ear. This finding underlines the indispensibility of in vivo testing of antibiotic effectiveness.
Pasteurellosis caused by Pasteurella multocida is an important and common disease of laboratory rabbits. The infection may be asymptomatic or manifest itself as rhinitis, sinusitis, conjunctivitis, otitis media, bronchopulmonary disease, multiple abscesses or genital infection (Ohder &. Wullenweber 1992) . Under stressful conditions, pneumonia and septicaemia may develop, resulting in high mortality.
Pasteurella-free rabbits are available for research, but many facilities continue to use contaminated rabbits because of lower initial costs.
Control of pasteurellosis is restricted mainly to preventive measures. Several strategies have been proposed including barrier housing (Weisbroth &. Scher 1969 , Ward 1973 , Scharf et al. 1981 ), vaccination (Lakeit et a1. 1976 , Percy et al. 1985 , Ringler et a1. 1985 , DiGiacomo et al. 1987 , Lu et al. 1991a and antimicrobial prophylaxis/therapy (Plant 1974 , Jaslow et al. 1981 , Rehg &. Lu 1981 , Accepted 14 May 1994 Welch et a1. 1987 , Broome &. Brooks 1991 , Gaertner 1991 . Although antibiotic therapy may improve clinical condition, it cannot usually eradicate P. multocida in rabbits [Jaslow et al. 1981 , Rehg &. Lu 1981 The fluoroquinolone enrofloxacin seems to be the most effective antibiotic for treating P. multocida-infections in rabbits and other species (Broome &. Brooks 1991 , Broome et ai. 1991 , Cabanes et a1. 1992 , Martin &. Ferri 1993 . P. multocida is very sensitive to enrofloxacin in vitro, with a minimal inhibitory concentration of 0.001 to 0.12I4g/ml (Scheer 1987aj , and the drug is widely dispersed when administered to the rabbit (Broome et a1. 1991 , Cabanes et al. 1992 .
Recently Broome and Brooks (1991) reported eradication of P. multocida from rabbits by subcutaneous injections of enrofloxacin. We tried to reproduce this experiment with special reference to asymptomatic carriers in order to assess the feasibility of this treatment in producing a colony free of P. multocida.
Materials and methods

Animals
Sixteen Chinchilla bastard (CBl rabbits (one female and 15 males) and 7 New Zealand White (NZW) male rabbits (Oryctolagus cuniculus), weighing 2.0-4.5 kg, were obtained from a commercial supplier (Lippische Versuchstierzucht, Hagemann, Germany). According to the supplier the animals carried Pasteurella multocida, Bordetella bronchiseptica and Encephalitozoon cuniculi. They were housed individually in stainless steel cages (54 cm wide x 51 cm deep x 42 cm high) or plastic cages (60 cm x 50 cm x 37 cm) with smooth, perforated floors. Cages were placed at least 10 cm apart. The lighting cycle was 12 h light/12 h dark. Room temperature was maintained at 21 ± 2°C and relative humidity was 60± 5%. Commercial pelleted diet (Kaninchen-Alleinfutter, Eggersmann, Germany) and water were available ad libitum.
Experimental design
Two experiments were performed: (1) Rabbits infected naturally with P. multocida were treated with enrofloxacin 193 after P. multocida had been tested for sensitivity to enrofloxacin. The presence of P. multocida in nasal cavities was monitored during and after treatment.
(2) Rabbits infected experimentally with P. multocida were necropsied after treatment with enrofloxacin. The presence of P. multocida was monitored in typical sites of occurrence and the concentration of enrofloxacin was determined in serum and in turbinate bones. In addition, the minimal inhibitory concentration of enrofloxacin for isolated P. multocida was determined.
Experiment 1
Eleven clinically unaffected rabbits [one CB female, 3 CB males and 7 NZW males) were confirmed as carriers of P. multocida by culture of nasal swabs and identification of isolated colonies [Ohder &. Wullenweber 1992) , one day prior to treatment. Three selected P. multocida isolates [from animals no. I, 2 and 6, see Table 1 ) were tested for in vitro sensitivity to enrofloxacin by the disc diffusion technique according to DIN 58940/ICS and the reommendations of the enrofloxacin (Baytril® ) producer. Enrofloxacin sensitivity was determined on DST agar (CM 261, Oxoid, Germany) The rabbits were injected subcutaneously with 5 mg enrofloxacin (Baytril® 2.5%, Bayer, Germany) per kg body weight at 12-h intervals for 10 days. Nasal swabs were cultured every 3 days during treatment and 7 days after the last injection. Samples were collected by inserting a sterile swab (Bakteriette 'Trocken Mini', EM-TE-Vertrieb, Germany) moistened with Brewer's thioglycollate medium (CM 23, Oxoid, Germany) 2 to 3 cm into both nares. The swab was streaked immediately onto blood agar (CM 55, Oxoid, Germany) containing 5% sheep blood and onto endo agar (CM 479, Oxoid, Germany) containing 0.04% basic fuchsin [BRSO, Oxoid, Germany). The plates were incubated at 3rC aerobically and examined at 24-and 48-h intervals for growth. Bacterial colonies were identified using standard criteria of cultural characteristics and Gram-staining (Ohder & Wullenweber 1992) .
Three selected cultures of P. multocida were typed biochemically and serologically using the indirect haemagglutination assayl [Jordache et a1. 1980) to identify capsular antigens.
Experiment 2
Twelve clinically unaffected rabbits (CB males), classified as negative for P. multocida by nasal cultures, were infected experimentally one day after the sampling to obtain P. multocida-positive animals. For this purpose P. multocida, from a naturally infected rabbit, was harvested from blood agar and suspended in 0.9% NaCl solution to a concentration of about 8 x 10 7 organisms per m!. The rabbits were infected intranasally by inserting a swab moistened with the P. multocida-suspension 2 to 3 cm deep into each nostril under sedation [40 mg of ketamine (Ketamin 10%, WDT, Germany)/kg body weight].
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Seven days after P. multocida-inoculation the rabbits were treated subcutaneously with 5 mg enrofloxacin/kg body weight as in experiment 1. Nasal swabs were taken and cultured one day prior to and every 3 days during treatment. One ml of blood was collected by heart puncture from 2 rabbits under anaesthesia (40 mg ketamine/kg body weight in combination with 4 mg xylazine/kg body weight [Rompun, Bayer, Germany] ) at 60, 120 and 180 min after the last enrofloxacin administration, just before being sacrificed by an intra cardiac injection of 0.3 ml T 61® (Hoechst, Germany)/kg body weight. One g of turbinate bones was taken from these rabbits immediately after euthanasia. Enrofloxacin concentrations in sera and in turbinate bones were determined by use of an agar diffusion biological assay2 with E. coli as test organism (Scheer 1987b) .
All rabbits were necropsied and nasal cavities, turbinates, tracheas, outer ears, cerebri and cerebelli were inspected and Table 2 ) isolated from the turbinate bones during necropsy were estimated utilizing the agar dilution assay3 [Scheer 1987a ).
Results
Experiment 1
Typing of P. multocida isolates: All three isolates were identified biochemically as P. multocida subsp. multocida. Serological typing showed that one isolate was type A, one type D and one untypable.
In vitro sensitivity of P. multocida to enrofloxacin: All three P. multocida isolates were sensitive to enrofloxacin (inhibition zone diameter~22 mm).
Isolation of bacteria from nasal swabs of rabbits infected naturally with P. multocida treated with enrofloxacin (Table  1) : Three rabbits lno. I, 4, 11) remained P. multocida-positive in nasal cultures during the whole period of treatment, but they 3Per£ormed at the BayerAG, GeschiHtsbereich VT-F,AntibakterielleChemotherapie, Leverkusen/Monheim,Germany.
were negative on the seventh day after the end of treatment. Two rabbits (no. 2, 8) showed alternately P. multocida-positive and -negative nasal cultures during the period of treatment. P. multocida was not recovered from the nares of the 6 remaining rabbits during treatment from the sixth day onward. Four rabbits (no. 5, 6, 7, 8) were P. multocida-positive again on the seventh day after the end of treatment. In addition, Bordetella bronchiseptica was detected from the nares of 10 rabbits one day prior to treatment. Two rabbits (no. 9, 10) became B. bronchiseptica-negative according to nasal cultures during treatment.
Experiment 2
Isolation of bacteria from nasal swabs of rabbits infected experimentally with P. multocida treated with enrofloxacin [ Table  2 ): Only one (no. 19) out of 12 infected rabbits was negative for P. multocida from nasal culture one day prior to treatment, but was found to be positive whilst being treated. Nine (75%) rabbits remained P. multocida-positive during the whole period of treatment and 5 of them developed moderate-to-severe rhinitis with mucopurulent discharge. One rabbit (no. 20) (Table 3) : Ten (83%) of the inoculated rabbits carried P. multocida in the nasal cavities after treatment. P. multocida was recovered from the turbinates of 11 (92%) rabbits and from the trachea of 2 (17%). In one (8%) rabbit P. multocida was isolated from the outer ear and in 5 (42%) from the middle ear. Three of them harboured P. multocida in both middle ears. In addition, one rabbit had a large subcutaneous P. multocidapositive neck abscess. P. multocida could not be detected in the brain samples. Minimal inhibitory concentrations: The minimal inhibitory concentrations of enrofloxacin for the two P. multocida isolates were 0.25 p.g/ml and 0.03 p.g/ml, respectively.
Enrofloxacin concentrations in serum and turbinate bones: The enrofloxacin concentrations in serum and turbinate bones determined at 3 intervals after the last administration are shown in Table 4 . In general, the antibiotic concentration in turbinate bones was greater than in serum samples. The highest enrofloxacin levels were measured 60 min after the last administration but at 180 min enrofloxacin concentrations in serum and turbinate bones still exceeded the minimal inhibitory concentrations determined in vitro.
Discussion
The purpose of our study was to investigate the efficacy of enrofloxacin in the elimination of P. multocida from asymptomatically infected rabbits in order to find a practical and inexpensive way to achieve a Pasteurella-free colony. We did not have control groups of infected but untreated rabbits as our routine health screening indicated that infection was persistent and availability of rabbits and space was limited.
In the present study, the administration of enrofloxacin failed to eliminate P. multocida from some asymptomatic carriers. Three (27%) of 11 naturallyinfected rabbits (Table 1 ) and 9 (75% of 12 experimentally-infected rabbits. (Table 2) remained P. multocida-positive in nasal cultures during the whole observation period. The difference between the 2 experiments might be due to the high number of organisms used for experimental infection (5 animals infected experimentally developed rhinitis).
Two naturally-infected rabbits [ Table 1 ) and one experimentally-infected rabbit ( (Glorioso et ai. 1982 , Holmes et al. 1984 .
Our results are in contrast to those of Broome and Brooks (1991) . They reported that all naturally infected rabbits (n = 8) treated subcutaneously with enrofloxacin 5 mg/kg every 12 h for 14 days) became nasal culture-negative within 72 h after the first application and remained negative throughout the treatment. At necropsy, P. multocida was detected only from the middle ear of one rabbit.
In our study, the isolation of P. multocida from the turbinates of 11 [92%) experimentally infected rabbits coincided with the recovery of P. multocida by nasal swabs at necropsy (Table 3 ). Only one animal was P. multocida-negative by nasal swab culture but P. multocida-positive by culture of turbinate bones.
The incidence of P. multocida in the middle ear was 42% (Table 3) . This site was also noted by other investigators (Holmes et al. 1984 , Nakagawa et ai. 1986 , Lukas et al. 1987 . In these studies P. multocida was isolated from the middle ear of 29 to 50% of the rabbits. Probably due to spread from the upper respiratory tract to the middle ear via the auditory tube as reported in other species (Beales 1967) . P. multocida could not be detected in cerebri and cerebelli though P. multocida has sometimes been found in brain in previous investigations (own unpublished observations).
Although P. multocida was sensitive to enrofloxacin in vitro and the enrofloxacin concentration in serum and in turbinate bones was greater than the determined minimal inhibitory concentrations, P. multocida was detected after treatment in nasal cavities and other organs (turbinates, trachea, middle ear, outer ear). The discrepancy between the efficacy of the antibiotic in vitro and in vivo illustrates the limitations of in vitro methods. Exposure to the antibiotic in vivo was unlikely to have been too short. Enrofloxacin has high bactericidal activity: 99% of E. coli, Klebsiella sp. and Salmonella sp., which have similar sensitivity as Pasteurellae, were killed 197 within 60 minutes in logarithmic growth phase in broth culture (Scheer 1987a) . We suppose that P. multocida colonizes 'niches' in which an effective enrofloxacin concentration cannot be achieved. Such sites could be the paranasal sinuses, auditory tubes or the middle ear which then serve as reservoirs for recolonization of the nasal mucosa by P. multocida. This may account for the inefficacy of enrofloxacin in the elimination of P. multocida from the rabbit nasal cavities. Kornerup Hansen (1995) made a similar observation in a colony of nude rats treated with different antibiotics over a period of 30 days. The primary target, Pasteurella pneumotropica, was suppressed by the treatment, but reappeared after ending the medication.
As an incidental finding, Bordetella bronchiseptica was cultured consistently from nasal swabs during treatment, in accordance with the results of Broome and Brooks (1991) . They assumed that the higher minimal inhibitory concentration for this organism was not attained in the upper respiratory tract. Ciliostasis caused by B. bronchiseptica may induce conditions suitable for adhesion of P. multocida, such as squamous metaplasia of mucosal cells (Bemis & Wilson 1985 , Deeb et ai. 1990 .
Despite failure to eliminate P. multocida J enrofloxacin may ameliorate clinical signs of respiratory pasteurellosis in rabbits (Broome & Brooks 1991) . In addition, we noted no adverse effects (gastroenteric disturbances) as after therapy with other antibiotics (Schatzmann et al. 1977 , Rehg & Lu 1981 , Thilsted et al. 1981 , Carman et al. 1984 , McElroy et ai. 1987 .
In conclusion, the only currently reliable strategy to achieve a Pasteurella-free colony consists of barrier housing [SPF colonies) after selecting rabbits free of P. multocida. Efforts in this direction range from Caesarian derivation with hand rearing (Scher et al. 1969 , Weisbroth & Scher 1969 to culling carriers. Colony surveillance or quarantine monitoring should be based on detection of P. multocida-infection by a combination of deep nasal culture and serological assay for IgG antibodies (Holmes et ai. 1986 , Deeb et 01. 1990 (1987) Pharmacokinetics of penicillin G in serum and nasal washings of Pasteurella multocida free and infected rabbits. Laboratory Animal Science 37, 65-8
